Cargando…

Attacking MALT1 for ABC-DLBCL therapy

Detalles Bibliográficos
Autor principal: Krappmann, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681482/
https://www.ncbi.nlm.nih.gov/pubmed/23455231
_version_ 1782273263554002944
author Krappmann, Daniel
author_facet Krappmann, Daniel
author_sort Krappmann, Daniel
collection PubMed
description
format Online
Article
Text
id pubmed-3681482
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-36814822013-06-17 Attacking MALT1 for ABC-DLBCL therapy Krappmann, Daniel Oncotarget Editorial Impact Journals LLC 2012-12-23 /pmc/articles/PMC3681482/ /pubmed/23455231 Text en Copyright: © 2012 Krappmann http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
spellingShingle Editorial
Krappmann, Daniel
Attacking MALT1 for ABC-DLBCL therapy
title Attacking MALT1 for ABC-DLBCL therapy
title_full Attacking MALT1 for ABC-DLBCL therapy
title_fullStr Attacking MALT1 for ABC-DLBCL therapy
title_full_unstemmed Attacking MALT1 for ABC-DLBCL therapy
title_short Attacking MALT1 for ABC-DLBCL therapy
title_sort attacking malt1 for abc-dlbcl therapy
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681482/
https://www.ncbi.nlm.nih.gov/pubmed/23455231
work_keys_str_mv AT krappmanndaniel attackingmalt1forabcdlbcltherapy